85 related articles for article (PubMed ID: 20164036)
41. Interleukin-4 Receptor Inhibition Targeting Metastasis Independent of Macrophages.
Cleary MM; Bharathy N; Abraham J; Kim JA; Rudzinski ER; Michalek JE; Keller C
Mol Cancer Ther; 2021 May; 20(5):906-914. PubMed ID: 33853867
[TBL] [Abstract][Full Text] [Related]
42. SNAIL Promotes Metastatic Behavior of Rhabdomyosarcoma by Increasing EZRIN and AKT Expression and Regulating MicroRNA Networks.
Skrzypek K; Kot M; Konieczny P; Nieszporek A; Kusienicka A; Lasota M; Bobela W; Jankowska U; Kędracka-Krok S; Majka M
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32664538
[TBL] [Abstract][Full Text] [Related]
43. Correlation between cell differentiation stage, types of invasion, and hematogenous metastasis in experimental rhabdomyosarcomas.
Herrera-Gayol A; Royal A; Babaï F
Exp Mol Pathol; 1995 Aug; 63(1):1-15. PubMed ID: 8759049
[TBL] [Abstract][Full Text] [Related]
44. Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas.
Boscolo Sesillo F; Sacco A
J Vis Exp; 2019 Sep; (151):. PubMed ID: 31566597
[TBL] [Abstract][Full Text] [Related]
45. KDM3A/Ets1/MCAM axis promotes growth and metastatic properties in Rhabdomyosarcoma.
Sobral LM; Sechler M; Parrish JK; McCann TS; Jones KL; Black JC; Jedlicka P
Genes Cancer; 2020; 11(1-2):53-65. PubMed ID: 32577157
[TBL] [Abstract][Full Text] [Related]
46. Metastatic rhabdomyosarcoma initially diagnosed on the bone marrow.
Quesada AE; Kanagal-Shamanna R
Blood; 2016 Oct; 128(17):2189. PubMed ID: 27789439
[No Abstract] [Full Text] [Related]
47. A Conversation with David Lyden.
Cold Spring Harb Symp Quant Biol; 2016; 81():326-327. PubMed ID: 28424338
[No Abstract] [Full Text] [Related]
48. Fusion-negative rhabdomyosarcoma orthotopic tongue xenografts for study of invasion, intravasation and metastasis in live animals.
Hammoudeh SM; Ng Y; Wei BR; Madsen TD; Simpson RM; Weigert R; Randazzo PA
bioRxiv; 2023 Nov; ():. PubMed ID: 38076999
[TBL] [Abstract][Full Text] [Related]
49. The hepatocyte growth factor/mesenchymal epithelial transition factor axis in high-risk pediatric solid tumors and the anti-tumor activity of targeted therapeutic agents.
Grundy M; Narendran A
Front Pediatr; 2022; 10():910268. PubMed ID: 36034555
[TBL] [Abstract][Full Text] [Related]
50. MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression.
Perrone C; Pomella S; Cassandri M; Pezzella M; Milano GM; Colletti M; Cossetti C; Pericoli G; Di Giannatale A; de Billy E; Vinci M; Petrini S; Marampon F; Quintarelli C; Taulli R; Roma J; Gallego S; Camero S; Mariottini P; Cervelli M; Maestro R; Miele L; De Angelis B; Locatelli F; Rota R
Front Oncol; 2022; 12():835642. PubMed ID: 35574376
[TBL] [Abstract][Full Text] [Related]
51. c-MET expression potentially contributes to the poor prognosis of rhabdomyosarcoma.
Du J; Wang Y; Meng L; Liu Y; Pang Y; Cui W; Zhang L; Li Z; Liu Q; Shang H; Liu C; Li F
Int J Clin Exp Pathol; 2018; 11(8):4083-4092. PubMed ID: 31949799
[TBL] [Abstract][Full Text] [Related]
52. Multiple Autologous Bone Marrow-Derived CD271
Milczarek O; Jarocha D; Starowicz-Filip A; Kwiatkowski S; Badyra B; Majka M
Stem Cells Transl Med; 2018 Jan; 7(1):20-33. PubMed ID: 29224250
[TBL] [Abstract][Full Text] [Related]
53. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.
Skrzypek K; Kusienicka A; Szewczyk B; Adamus T; Lukasiewicz E; Miekus K; Majka M
Oncotarget; 2015 Oct; 6(31):31378-98. PubMed ID: 26384300
[TBL] [Abstract][Full Text] [Related]
54. Understanding the Interplay between Expression, Mutation and Activity of ALK Receptor in Rhabdomyosarcoma Cells for Clinical Application of Small-Molecule Inhibitors.
Peron M; Lovisa F; Poli E; Basso G; Bonvini P
PLoS One; 2015; 10(7):e0132330. PubMed ID: 26147305
[TBL] [Abstract][Full Text] [Related]
55. MET receptor is a potential therapeutic target in high grade cervical cancer.
Miekus K; Pawlowska M; Sekuła M; Drabik G; Madeja Z; Adamek D; Majka M
Oncotarget; 2015 Apr; 6(12):10086-101. PubMed ID: 25888626
[TBL] [Abstract][Full Text] [Related]
56. A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma.
Olanich ME; Barr FG
Expert Opin Ther Targets; 2013 May; 17(5):607-23. PubMed ID: 23432728
[TBL] [Abstract][Full Text] [Related]
57. The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation.
Miekus K; Lukasiewicz E; Jarocha D; Sekula M; Drabik G; Majka M
Cell Death Dis; 2013 Jan; 4(1):e459. PubMed ID: 23328666
[TBL] [Abstract][Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
